Cold Chain Market Size and Share | Trend Analysis | B Medical Systems (US), Blue Star Limited (India), Thermo Fisher Scientific (US)

Cold Chain Products Market in terms of revenue was estimated to be worth $569 million in 2022 and is poised to reach $711 million by 2027, growing at a CAGR of 4.5% from 2022 to 2027 according to a new report by MarketsandMarkets™. Factors such as the rising zoonotic disease concerns, Rising use of immunoglobulins and other plasma products in a range of therapeutic areas and Increasing demand for Plasma-derived medicinal products driving the growth of the Cold Chain Products Market for Plasma Fractionation. However, shortage of trained manpower & limited resources to maintain the equipment and Environmental concerns regarding greenhouse gas emissions will be challenges in the growth of this market during the forecast period.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=159802939&utm_source=Openpr&utm_campaign=Paid&utm_content=Referral

In this report, the Cold Chain Products Market for Plasma Fractionation is segmented based on type, end user, and region.

"Temperature monitoring devices segment is expected to witness the fastest growth in the forecast period."

The Cold Chain Products for Plasma Fractionation market is categorized into seven types, including Ultra-low temperature freezers, Plasma freezers, Temperature monitoring devices, Plasma contact shock freezers, Blood transport boxes, Ice-lined refrigerators, and Others. Among these categories, the Temperature monitoring devices segment is projected to experience the highest growth rate from 2022 to 2027. Increased research and development investment in medical devices such as medical freezers and refrigerators are additional factors that are anticipated to drive market growth during the forecasted period

"Blood collection centers and blood component providers accounted for the largest share of the Cold Chain Products Market for Plasma Fractionation in 2021."

The Cold Chain Products Market for Plasma Fractionation is categorized into different end users, including Blood collection centers and blood component providers, Hospitals and transfusion centers, Clinical research laboratories, and Others. Among these, the Blood collection centers, and blood component providers segment held the fastest-growing market for cold chain products for plasma fractionation in 2021. This significant market share can be attributed to factors such as the increasing prevalence of diseases like hemophilia, immune deficiency disorders, and liver diseases, as well as the growing aging population.

"North America accounted for the largest share of the Cold Chain Products Market for Plasma Fractionation in 2021"

The Cold Chain Products Market for Plasma Fractionation is segmented into five geographical regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2021, North America emerged as the dominant market for Cold Chain Products for Plasma Fractionation worldwide. The increasing demand for plasma freezers and the availability of advanced cold storage devices for laboratories are expected to be major driving factors for market growth in North America. The region's substantial market share can be attributed to its well-developed healthcare infrastructure and the continuous investment in research and development of medical devices such as medical freezers and refrigerators.

Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=159802939&utm_source=Openpr&utm_campaign=Paid&utm_content=Referral

Cold Chain Products Market Dynamics:

Drivers:

Growing adoption of hybrid operating rooms

Restraints:

Increasing adoption of refurbished medical displays

Opportunities:

Increasing investments from government bodies and private players in healthcare sectors in emerging economies

Challenges:

Adoption of consumer-grade displays

Key Market Players:

The prominent players in the global Cold Chain Products Market for Plasma Fractionation are B Medical Systems (US), Blue Star Limited (India), Thermo Fisher Scientific (US), Godrej and Boyce Manufacturing Co. Ltd. (India), Haier Biomedical (China), Eppendorf SE (Germany), Avantor, Inc. (US), Biolife Solutions Inc. (US), and Helmer Scientific Inc. (US).

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=159802939&utm_source=Openpr&utm_campaign=Paid&utm_content=Referral

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
thbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

About MarketsandMarkets™:

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

This release was published on openPR.